Medicus Pharma Ltd. (MDCX)
NASDAQ: MDCX · Real-Time Price · USD
2.100
-0.140 (-6.25%)
At close: Aug 13, 2025, 4:00 PM
2.100
0.00 (0.00%)
Pre-market: Aug 14, 2025, 8:35 AM EDT

Company Description

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets.

It develops SkinJect for the treatment of basal cell carcinoma. The company was founded in 2015 and is headquartered in Toronto, Canada.

Medicus Pharma Ltd.
Medicus Pharma logo
Country Canada
Founded 2008
Industry Drug Manufacturers - General
Sector Healthcare
CEO Raza Bokhari

Contact Details

Address:
One First Canadian Place, Suite 3400
Toronto, ON M5X 1A4
Canada
Website medicuspharma.com

Stock Details

Ticker Symbol MDCX
Exchange NASDAQ
Reporting Currency USD
CIK Code 0001997296
ISIN Number CA58471K2020
Employer ID 98-1778211
SIC Code 2834

Key Executives

Name Position
Dr. Raza Bokhari M.B.A., M.D., MBA Chief Executive Officer and Executive Chairman
James P. Quinlan CPA Chief Financial Officer
Dr. Edward J. Brennan Jr., F.A.C.S., FACS, M.D. Chief Scientific Officer and Head of Research & Development Program
Carolyn Bonner President
Andrew Alasdair Smith Chief Operating Officer
Anna Baran-Djokovic J.D. Senior Vice President of Investor Relations
Viktoriia Slepeniuk Senior Vice President of Public Relations
Dr. Faisal Mehmud M.D. Chief Medical Officer
Maryann Adesso Chief of Staff and Corporate Secretary

Latest SEC Filings

Date Type Title
Aug 12, 2025 SCHEDULE 13G/A Filing
Aug 12, 2025 SCHEDULE 13G/A Filing
Aug 12, 2025 424B3 Prospectus
Aug 12, 2025 424B3 Prospectus
Aug 12, 2025 253G2 Acc-no: 0001493152-21-027927 (33 Act)
Aug 12, 2025 424B3 Prospectus
Aug 11, 2025 10-Q Quarterly Report
Aug 4, 2025 8-K Current Report
Jul 30, 2025 8-K Current Report
Jul 23, 2025 424B3 Prospectus